Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/09/2012EP2448971A1 Methods for treatment of muscular dystrophy
05/09/2012EP2448964A1 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor
05/09/2012EP2448954A1 Synthesis of cyclic diguanosine monophosphate and thiophosphate analogs thereof
05/09/2012EP2448953A1 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thatreof as a2ar agonists
05/09/2012EP2448952A2 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof
05/09/2012EP2448949A1 Crystalline form of fosamprenavir calcium
05/09/2012EP2448946A1 2-carboxamide cycloamino ureas useful as pi3k inhibitors
05/09/2012EP2448945A1 Crystalline forms of prasugrel salts
05/09/2012EP2448943A1 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
05/09/2012EP2448942A1 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS
05/09/2012EP2448941A2 Pyrazolopyrimidine jak inhibitor compounds and methods
05/09/2012EP2448940A2 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
05/09/2012EP2448939A1 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
05/09/2012EP2448938A1 Pyrimidinones as pi3k inhibitors
05/09/2012EP2448937A1 Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
05/09/2012EP2448935A1 Substituted 2-carboxamide cycloamino ureas
05/09/2012EP2448933A1 Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
05/09/2012EP2448932A1 Novel 6-morpholin-4-yl-pyrimidin-4-(3h)-one derivatives, and the pharmaceutical preparation thereof as akt(pkb) phosphorylation inhibitors
05/09/2012EP2448931A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448930A1 Covalent inhibition of bacterial quorum sensing
05/09/2012EP2448929A1 Novel conjugates, preparation thereof, and therapeutic use thereof
05/09/2012EP2448928A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/09/2012EP2448927A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
05/09/2012EP2448926A1 Flavin derivatives
05/09/2012EP2448924A2 Pyrazole derivatives, preparation thereof, and therapeutic use thereof
05/09/2012EP2448922A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones
05/09/2012EP2448921A1 Aryl indole derivatives
05/09/2012EP2448920A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/09/2012EP2448919A2 Solubility and stability enchancing pharmaceutical formulation
05/09/2012EP2448637A1 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
05/09/2012EP2448592A1 Vaccines and compositions against streptococcus pneumoniae
05/09/2012EP2448590A1 Medicinal carbohydrates for treatment of respiratory conditions
05/09/2012EP2448589A1 Method for improving bioavailability of latanoprost
05/09/2012EP2448588A1 Methods and compositions for treating cancer
05/09/2012EP2448587A1 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
05/09/2012EP2448586A1 New medical use
05/09/2012EP2448585A1 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
05/09/2012EP2448583A1 Substituted 4-hydroxypyrimidine-5-carboxamides
05/09/2012EP2448582A1 Therapeutic compounds and compositions
05/09/2012EP2448581A1 Therapeutic compositions and related methods of use
05/09/2012EP2448580A1 Eltoprazine for the treatment of anxiety
05/09/2012EP2448579A1 Eltoprazine for the treatment of weight disorders
05/09/2012EP2448578A1 New medical use
05/09/2012EP2448577A1 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders
05/09/2012EP2448576A2 Solubility enhancing pharmaceutical composition
05/09/2012EP2448575A2 Pharmaceutical composition increasing solubility and stability
05/09/2012EP2448574A1 Synthesis and use of fluorophore-tagged antimalarials
05/09/2012EP2448573A1 Medicament for the long term nsaid use
05/09/2012EP2448572A1 Methods of identifying a patient population eligible for treatment with nitric oxide via inhalation
05/09/2012EP2448570A1 L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin
05/09/2012EP2448569A2 Pharmacology of visual cycle modulators
05/09/2012EP2448568A1 Improved formulation for nonsurgical exogenous crosslink therapy
05/09/2012EP2448565A2 Transdermal composition comprising tolterodine
05/09/2012EP2448564A2 Solubility enhancing pharmaceutical formulation
05/09/2012EP2448563A2 3-cyanoquinoline tablet formulations and uses thereof
05/09/2012EP2448562A2 Raloxifene composition
05/09/2012EP2448561A1 Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
05/09/2012EP2448558A1 Local therapeutic release device
05/09/2012EP2448432A1 Nutritional composition comprising cereal beta-glucan and salacia extract
05/09/2012EP2448413A1 Slow release magnesium composition and uses thereof
05/09/2012EP2448412A1 Chromium complexes as enhancers of brain glucose transporters
05/09/2012EP2448411A1 A method of treatment of a neurological disorder
05/09/2012EP2448410A1 Treatment and prevention of dengue virus infections
05/09/2012EP2448409A1 Phosphorus containing quinazoline compounds and methods of use
05/09/2012EP2448408A1 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
05/09/2012EP2448407A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
05/09/2012EP2448406A1 Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
05/09/2012EP2324008B1 3,4-diarylpyrazoles as protein kinase inhibitors
05/09/2012EP2323971B1 Salicylamide derivatives as nicotinic alpha 7 modulators
05/09/2012EP2321308B1 Piperidine gpcr agonists
05/09/2012EP2321284B1 Sulfone substituted quinazoline derivatives as immune-modulators for the treatment of inflammatory and allergic diseases
05/09/2012EP2318413B1 Pyrrolobenzodiazepines
05/09/2012EP2318399B1 Piperidinyl gpcr agonists
05/09/2012EP2303871B1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
05/09/2012EP2287162B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
05/09/2012EP2287161B1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
05/09/2012EP2280953B1 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
05/09/2012EP2274297B1 Pyrrolidinone glucokinase activators
05/09/2012EP2244701B1 Corroles for neuroprotection and neurorescue
05/09/2012EP2213292B1 Double-stranded oligonucleotides
05/09/2012EP2100605B9 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
05/09/2012EP1968574B9 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
05/09/2012EP1888589B1 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
05/09/2012EP1786788B1 Substituted triazines as prion protein ligands and their use to detect or remove prions
05/09/2012EP1730131B1 Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
05/09/2012EP1715863B1 Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors
05/09/2012EP1679063B1 Novel liquid preparation composition
05/09/2012EP1651646B1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i
05/09/2012EP1644342B1 Arylpyrimidines useful for the treatment of sex hormone-related conditions such as endometriosis, prostate cancer and the like
05/09/2012EP1631281B1 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
05/09/2012EP1613588B1 2-propylidene-19-nor-vitamin d compounds
05/09/2012EP1609798B1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
05/09/2012EP1605776B1 Method and composition for preventing or reducing diarrhea
05/09/2012EP1603510B1 Methods of improving skin quality
05/09/2012EP1598337B1 Method of obtaining an antiepileptic agent
05/09/2012EP1585502B9 Fast-disintegrating solid dosage forms being not friable and comprising pullulan
05/09/2012EP1501467B1 Heterocyclo inhibitors of potassium channel function
05/09/2012EP1492536B1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/09/2012EP1480960B1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
05/09/2012EP1423107B1 Fatty alcohol drug conjugates
1 ... 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 ... 7860